Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) (2010 - 2026)
Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | 12.38 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 3.89 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 7.42 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 4.06 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | 1.82 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 1.56 Bn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 3.10 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 2.55 Bn |
| 10 | Pacific Biosciences Of California | 417.44 Mn | 141.48 Mn | 12.84 Mn | 24.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.38 Mn |
| Mar 31, 2026 | 24.38 Mn |
| Dec 31, 2025 | 24.15 Mn |
| Dec 31, 2025 | 24.15 Mn |
| Sep 30, 2025 | 22.13 Mn |
| Sep 30, 2025 | 22.13 Mn |
| Jun 30, 2025 | 23.10 Mn |
| Jun 30, 2025 | 23.10 Mn |
| Mar 31, 2025 | 24.79 Mn |
| Mar 31, 2025 | 24.79 Mn |
| Dec 31, 2024 | 30.51 Mn |
| Dec 31, 2024 | 30.51 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Jun 30, 2024 | 34.91 Mn |
| Jun 30, 2024 | 34.91 Mn |
| Mar 31, 2024 | 37.29 Mn |
| Mar 31, 2024 | 37.29 Mn |
| Dec 31, 2023 | 36.43 Mn |
| Dec 31, 2023 | 36.43 Mn |